221 filings
Page 6 of 12
D
2xht3d38 h0w
11 Dec 19
$60.37M in equity, sold $60.37M, 5 investors
4:15pm
8-K
eyu723
5 Dec 19
Athenex Announces $60 Million Private Placement
8:05am
8-K
byqas1fmzim6gsx1ogl
7 Nov 19
Athenex, Inc. Announces Third Quarter 2019 Financial Results
7:05am
8-K
wtczgm z22t5j3
9 Sep 19
Regulation FD Disclosure
7:01am
8-K
wtw60dd
7 Aug 19
Positive Phase III results of Oral Paclitaxel show statistically significant improvement in overall response rate in metastatic breast cancer
6:32am
8-K
0zuw3rzs35 rjn5
2 Aug 19
Athenex Provides an Update Regarding the Vasopressin Case
9:14am
S-3ASR
5sld3 blv5e7d
23 Jul 19
Automatic shelf registration
4:52pm
UPLOAD
vktkyi6d1ikaoncs
22 Jul 19
Letter from SEC
12:00am
CORRESP
7vph 6kmxd84005xr
2 Jul 19
Correspondence with SEC
12:00am
UPLOAD
u3yezd30
26 Jun 19
Letter from SEC
12:00am
8-K
qpme3h ou1g
13 Jun 19
Submission of Matters to a Vote of Security Holders
7:00am
8-K
u4tznb1sn1ww
6 Jun 19
Other Events
7:05am
CORRESP
0irrh
31 May 19
Correspondence with SEC
12:00am
UPLOAD
t013ngyzkmv4dd89tv
17 May 19
Letter from SEC
12:00am
D
ugywcfis5v
15 May 19
$100M in equity, sold $100M, 4 investors
12:00am
8-K
r1yswmi
9 May 19
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update
7:05am
8-K
2trjfld t5ta
6 May 19
Athenex Announces $100 Million Private Placement
8:06am